Upstream Processing

Catalent to replace steel bioreactors with single use

Catalent plans single use overhaul of bioreactors

By Natalie Morrison

Catalent has replaced all stainless steel bioreactors at its biologics facility in Middleton, Wisconsin with single-use techs citing cost and flexibility advantages.

CRL to buy WuXi for $1.6bn

CRL to buy WuXi for $1.6bn

By Nick Taylor

Charles River Laboratories (CRL) is to acquire WuXi PharmaTech for $1.6bn (€1.2bn), creating a global CRO capable of offering fully integrated services from molecule creation to first-in-human testing.

Follow us


View more